iAnthus Capital Holdings Inc ITHUF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ITHUF is a good fit for your portfolio.
News
-
iAnthus Announces Strategic Partnership with Timeless Vapes to Bring a Leading Lifestyle Brand to New Jersey
-
iAnthus Provides Update on Executive Team
-
iAnthus Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results
-
iAnthus Announces Resignation of Director
-
iAnthus Announces Extension of New Jersey Bridge Notes
-
iAnthus Announces Restatement of Third Quarter 2023 Financial Results
Trading Information
- Previous Close Price
- $0.02
- Day Range
- $0.02–0.02
- 52-Week Range
- $0.01–0.04
- Bid/Ask
- $0.02 / $0.02
- Market Cap
- $126.35 Mil
- Volume/Avg
- 10,756 / 185,040
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.77
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 802
- Website
- https://www.ianthus.com
Comparables
Valuation
|
Metric
|
ITHUF
|
GLAS.A.U
|
CURA
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | — | 6.79 | 3.61 |
Price/Sales | 0.77 | 3.85 | 2.73 |
Price/Cash Flow | — | 66.07 | 64.41 |
Price/Earnings
ITHUF
GLAS.A.U
CURA
Financial Strength
|
Metric
|
ITHUF
|
GLAS.A.U
|
CURA
|
|---|---|---|---|
Quick Ratio | 0.14 | 0.38 | 0.31 |
Current Ratio | 0.36 | 0.56 | 0.85 |
Interest Coverage | −1.05 | −7.98 | −0.24 |
Quick Ratio
ITHUF
GLAS.A.U
CURA
Profitability
|
Metric
|
ITHUF
|
GLAS.A.U
|
CURA
|
|---|---|---|---|
Return on Assets (Normalized) | −24.26% | −7.05% | −3.72% |
Return on Equity (Normalized) | — | −18.87% | −10.45% |
Return on Invested Capital (Normalized) | −29.87% | −6.36% | −2.20% |
Return on Assets
ITHUF
GLAS.A.U
CURA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Lvcglxztb | Gvxlr | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Hjtwlnlcz | Bsy | $68.9 Bil | |
HLN
| Haleon PLC ADR | Smkcvdw | Fmqm | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xwjyrfm | Slcsd | $14.7 Bil | |
VTRS
| Viatris Inc | Gjvbpntk | Yvc | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cxfmsvvlc | Wsd | $11.9 Bil | |
CTLT
| Catalent Inc | Rwzpqhw | Btqhnp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Gksnlfbj | Dhxw | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Jpmfstjz | Lmwy | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Kbkgfkfw | Jjkjzc | $3.5 Bil |